INS and diabetes mellitus: P5 was compared against exendin‐4 in a variety of mouse models of diabetes, showing an unusual pharmacodynamic profile including greater acute anti‐hyperglycaemic efficacy than exendin‐4 but reduced insulin secretion and unaffected insulin sensitivity.